Evidence map›Paper›PMID 28336936›Full record

ArticleLeukemia2017

No evidence for microsatellite instability in acute myeloid leukemia.

C J Walker, A-K Eisfeld, L K Genutis, M Bainazar, J Kohlschmidt, K Mrózek, A J Carroll, J E Kolitz, B L Powell, E S Wang and 4 more

Open access · greenAbstract read
In one paragraph

Article in Leukemia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. STR profiling in a cohort of Saudi patients with acute leukemia.Journal of Taibah University Medical Sciences · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.Thyroid : official journal of the American Thyroid Association · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

C J WalkerThe Ohio State University Comprehensive Cancer Center, Columbus OH, USA.
A-K EisfeldThe Ohio State University Comprehensive Cancer Center, Columbus OH, USA.
L K GenutisThe Ohio State University Comprehensive Cancer Center, Columbus OH, USA.
M BainazarThe Ohio State University Comprehensive Cancer Center, Columbus OH, USA.
J KohlschmidtThe Ohio State University Comprehensive Cancer Center, Columbus OH, USA.
K MrózekThe Ohio State University Comprehensive Cancer Center, Columbus OH, USA.
A J CarrollDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
J E KolitzDepartment of Medicine, Monter Cancer Center, Hofstra North Shore-Long Island Jewish School of Medicine, Lake Success, NY, USA.
B L PowellDepartment of Internal Medicine, Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.
E S WangDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
R M StoneDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
R BundschuhDepartment of Physics, The Ohio State University, Columbus, OH, USA.
A de la ChapelleThe Ohio State University Comprehensive Cancer Center, Columbus OH, USA.
C D BloomfieldThe Ohio State University Comprehensive Cancer Center, Columbus OH, USA.
The Ohio State University · USDana-Farber Cancer Institute · USNorthwell Health · USRoswell Park Comprehensive Cancer Center · USUniversity of Alabama at Birmingham · USWake Forest Baptist Comprehensive Cancer Center

Funding

Member Site CoreU10CA180821 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Evanthia Galanis · 2014 to 2026
$177.3M
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Statistics CoreU10CA180882 · NCI · MAYO CLINIC ROCHESTER · PI Sumithra Jay Mandrekar · 2014 to 2026
$115.0M
THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCEU24CA196171 · NCI · WASHINGTON UNIVERSITY · PI Mine Cicek, Wendy Frankel · 2015 to 2026
$35.0M
SPORE Leukemia Tissue BankP50CA140158 · NCI · OHIO STATE UNIVERSITY · PI BLOOMFIELD, CLARA D · 2009 to 2013
$11.2M
OSU as Network Lead Academic Participating Site for the NCI NCTNU10CA180850 · NCI · OHIO STATE UNIVERSITY · PI BLUM, KRISTIE A, CHAKRAVARTI, ARNAB · 2014 to 2018
$6.8M
Cancer and Leukemia Group B - The Ohio State UniversityU10CA077658 · NCI · OHIO STATE UNIVERSITY · PI BLOOMFIELD, CLARA D · 1998 to 2013
$6.0M
ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" TherapieU10CA180861 · NCI · OHIO STATE UNIVERSITY · PI BLOOMFIELD, CLARA D, MARCUCCI, GUIDO · 2014 to 2018
$3.4M
NCI NIH HHS P30 CA016058NCI NIH HHS P50 CA140158NCI NIH HHS U10 CA077658NCI NIH HHS U10 CA180821NCI NIH HHS U10 CA180850NCI NIH HHS U10 CA180861NCI NIH HHS U10 CA180882NCI NIH HHS U24 CA196171
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Microsatellite InstabilityAllelesCohort StudiesHumansLeukemia, Myeloid, AcutePolymerase Chain Reaction

Identifiers

PMID28336936
PMCPMC5462842
OpenAlexW2598563895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.